Search for companies, drugs, and catalysts
Phase 2
Development Phase
2
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
Ruxolitinib Cream Phase 3 Results Expected
Ruxolitinib Cream • Nonsegmental Vitiligo With Genital Involvement
Target Indication
Nonsegmental Vitiligo With Genital Involvement
Clinical Trial
Last updated: 12/4/2025
INCY
Incyte Corporation